The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Janux Therapeutics(NASDAQ:JANX) 
Janux Therapeutics is an innovative clinical-stage biopharmaceutical company developing next-generation therapeutics based on applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms to better treat patients suffering f...
Website: https://www.januxrx.com/
Founded: 2017
IPO Price: $17 (Jun 11, 2021)
CEO: David Campbell
Sector:
Industry:
Share this website to your friends
Janux Therapeutics Days Payable Outstanding ttm (DPO)
Janux Therapeutics Days Receivable Outstanding ttm (DSO)
Janux Therapeutics Days Inventory Outstanding ttm (DIO)
Janux Therapeutics Op Cashflow Per Share ttm
Janux Therapeutics Free Cashflow Per Share ttm
Janux Therapeutics Cash Per Share ttm
Janux Therapeutics P/S ratio ttm
Janux Therapeutics (GAAP) P/E ratio ttm
Janux Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.